Literature DB >> 9724158

Spontaneous seroconversion in chronic hepatitis B: role of mutations in the precore/core gene.

E Schulte-Frohlinde1, G R Foster.   

Abstract

The mechanism underlying spontaneous clearance of hepatitis B e antigen (HBeAg) and the appearance of antibodies (anti-HBe seroconversion) in chronic hepatitis B is not known. Previous studies have demonstrated mutations within the precore/core gene before, during, and after seroconversion, suggesting that the emergence of mutations in the core gene may abrogate tolerance and that this event may act as a general principle for the initiation of the clearance of HBeAg. To investigate this hypothesis, we studied three patients with adult-acquired chronic hepatitis B virus (HBV) infection before spontaneous seroconversion by sequential sequencing and single-stranded conformation polymorphism (SSCP) analysis of the entire precore/core genome. In one patient, a new viral strain appeared six months before seroconversion, but no mutations or new viral strains could be detected in the other two patients. SSCP analysis confirmed the sequencing results and revealed no evidence for the emergence of new viral subpopulations before seroconversion. These results suggest that the appearance of nucleotide changes within the precore/core region of the dominant viral strain is not a prerequisite for the induction of seroconversion in patients with chronic hepatitis B virus infection acquired during adulthood.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724158     DOI: 10.1023/a:1018871300703

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection.

Authors:  T Ehata; M Omata; O Yokosuka; K Hosoda; M Ohto
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  An optimized freeze-squeeze method for the recovery of DNA fragments from agarose gels.

Authors:  D Tautz; M Renz
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.

Authors:  Y F Liaw; C M Chu; I J Su; M J Huang; D Y Lin; C S Chang-Chien
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

4.  High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.

Authors:  H Bozkaya; B Ayola; A S Lok
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

5.  Serology of acute exacerbation in chronic hepatitis B virus infection.

Authors:  T Maruyama; S Iino; K Koike; K Yasuda; D R Milich
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

6.  Transmission of hepatitis B virus analyzed by conformation-dependent polymorphisms of single-stranded viral DNA.

Authors:  J H Yusof; A J Flower; C G Teo
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

7.  Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection.

Authors:  A S Lok; C L Lai; P C Wu; E K Leung; T S Lam
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

8.  Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.

Authors:  P Karayiannis; M J Fowler; A S Lok; C Greenfield; J Monjardino; H C Thomas
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

9.  Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.

Authors:  J H Hoofnagle; G M Dusheiko; L B Seeff; E A Jones; J G Waggoner; Z B Bales
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

10.  Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants.

Authors:  W F Carman; M Thursz; S Hadziyannis; G McIntyre; K Colman; A Gioustoz; G Fattovich; A Alberti; H C Thomas
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.